The subject expert committee on Covid-19 vaccines has recommended the national drug regulator to grant an emergency use authorisation to Bharat Biotech’s Covaxin for the age group of 2 to 18 years, health ministry sources said. The development is significant as India is just one step away from a Covid-19 vaccine…
Bharat Biotech’s Covaxin is overall 77.8 per cent effective against Covid, the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed. The vaccine offers “65.2 per cent protection”, it said, against the rapidly…
The Co-WIN portal has now introduced an option enabling users to link their vaccination certificates to their passport numbers. This move has come as a big relief to those Indians who need to furnish their vaccination details before travelling abroad. The official Twitter handle of the Aarogya Setu App has shared a…
A Brazilian congressman who has denounced alleged wrongdoing in a 1.6 billion reais ($323 million) COVID-19 vaccine contract signed by Brazil’s government arrived at a Senate commission inquiry on Friday wearing a bullet-proof vest for safety. Congressman Luis Miranda and his brother Luis Ricardo Miranda,…
The government on Friday extended deadlines for various income tax compliances and said the amount paid by an employer to employees for COVID-19 treatment would be tax-exempt. Also, payment received from employer by family members in case of death of an employee due to COVID-19 would be exempt from income tax. The…
Bharat Biotech and the World Health Organization held a ‘pre-submission’ meeting on Wednesday for international emergency use listing (EUL) of Covaxin, its COVID-19 vaccine. The meeting was to give the company a chance to receive guidance from WHO authorities before the final submission. No details…
HIGHLIGHTS 29 crore doses of Covid-19 vaccines have been administered to date 22 cases of Delta Plus variant have been reported in India: Rajesh Bhushan Genome sequencing of a total of 45,000 samples has been conducted at 28 INSACOG labs Covaxin and Covishield are effective against the Delta variant of coronavirus,…
Vaccine manufacturer Bharat Biotech has said the rate at which it was supplying its Covid-19 vaccine to the government was “not sustainable in the long run” and a differential price in the private markets was justified to “offset parts of the costs”. In a detailed statement over the pricing…
All private hospitals and nursing homes have been told not to administer Bharat Biotech’s COVID-19 vaccine to those who are coming in for their first jab. Covaxin in Delhi will be administered only to those in the 18-44 age group who need the second dose, the Delhi government said in a statement on Sunday. All…
India has cumulatively administered more than 20 crore vaccine doses up till 7 pm on May 25, reported news agency ANI. As many as 20,04,94,991 vaccine jabs have been administered as of May 25. The daily count of coronavirus cases in the country fell below the 2-lakh mark after over a month taking the total tally of…